Before you and your care team add GLP-1s, heres what experts say you should think about: You Might Finally Be Able to Get Help for Your Other Health Conditions Unfortunately, many people with bipolar disorder meet the on-label criteria for GLP-1s like obesity or type 2 diabetes yet are not being treated, says McIntyre
Key signals include no major malware/phishing detections, strong independent trust, and favorable customer feedback from 47 reviews
Semaglutide is FDA-approved for type 2 diabetes management (Ozempic, Rybelsus), cardiovascular risk reduction in patients with type 2 diabetes and established cardiovascular disease (Ozempic), chronic weight management in obesity or overweight with comorbidities (Wegovy), and cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight (Wegovy)
Patients shouldn't expect to pick up a medication immediately on July 1, Francavilla added
10.1210/jc.2011-2407 13 GierB.MatveyenkoA
European Medicines Agency (2017)